首页 > 最新文献

JAMA ophthalmology最新文献

英文 中文
Fatty Acid Supplementation and Retinopathy of Prematurity 脂肪酸补充与早产儿视网膜病变
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-29 DOI: 10.1001/jamaophthalmol.2025.5994
Pia Lundgren, Staffan Nilsson, Aldina Pivodic, Anders K. Nilsson, Lois E. H. Smith, Ann Hellström
This secondary analysis of a randomized clinical trial examines what risk factors for retinopathy of prematurity are influenced by supplementation with arachidonic acid and docosahexaenoic acid and their interactions with severe retinopathy of prematurity.
这是一项随机临床试验的二次分析,研究补充花生四烯酸和二十二碳六烯酸对早产儿视网膜病变的危险因素的影响,以及它们与严重早产儿视网膜病变的相互作用。
{"title":"Fatty Acid Supplementation and Retinopathy of Prematurity","authors":"Pia Lundgren, Staffan Nilsson, Aldina Pivodic, Anders K. Nilsson, Lois E. H. Smith, Ann Hellström","doi":"10.1001/jamaophthalmol.2025.5994","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5994","url":null,"abstract":"This secondary analysis of a randomized clinical trial examines what risk factors for retinopathy of prematurity are influenced by supplementation with arachidonic acid and docosahexaenoic acid and their interactions with severe retinopathy of prematurity.","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"15 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146071500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure. 一种新的地理萎缩结果测量方法的建议、推导和外部验证。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-29 DOI: 10.1001/jamaophthalmol.2025.6002
Jintong Hou,Leon von der Emde,Souvick Mukherjee,Emily Vance,Elvira Agrón,Amitha Domalpally,Emily Y Chew,Tiarnán D L Keenan,
ImportanceExisting outcome measures for tracking geographic atrophy (GA) progression have disadvantages. As a functional measure, best-corrected visual acuity (BCVA) is associated with quality of life and recognized by regulators but is subjective and noisy (ie, with a high level of test-retest variability). As a structural measure, GA area is objective and less noisy (ie, with a low level of test-retest variability) but assumes all macular locations are equally important.ObjectiveTo derive and validate a novel outcome measure, the Geographic Atrophy Weighted-by-Acuity Index (GAWAIN). This was designed as a structural measure to align with BCVA by empirical weighting of macular pixels arranged in concentric annuli.ExposuresDerivation and validation of novel GA outcome measure.Design, Setting, and ParticipantsThis prognostic study included outcome measure development using in silico analyses. The data for the training/validation set were taken from participants in the Age-Related Eye Disease Study 2 (AREDS2) study (4313 visits, 1528 eyes), and for the external validation set, data were taken from participants in the GA Minocycline Trial (218 visits, 35 eyes). Study data were analyzed from April to October 2025.Main Outcomes and MeasuresPearson correlation between the novel GA outcome measure (0-100) and BCVA (35-85 letter score); area under receiver operating characteristic curve for clinical BCVA thresholds. The macula was divided into 60 concentric annuli; GA occupancy of each annulus was calculated. Annulus weights were derived using ridge regression, with GA involvement of each annulus and age as predictors and BCVA deficit (100 - BCVA) as outcome.ResultsTraining/validation was performed on 1120 participants (mean [SD] age, 77.1 [7.0] years; 645 female [57.6%]), and external validation was performed on 35 participants (mean [SD] age, 74.3 [7.1] years; 21 female [60.0%]). The annulus weights exhibited a decelerating decline with macular eccentricity. On internal validation, the novel GA outcome measure was correlated more strongly with BCVA deficit than GA area (Pearson r = 0.58 vs 0.32, difference = 0.27; 95% CI, 0.23-0.31; P < .001). This was also true on external validation for color fundus photograph-defined GA (Pearson r = 0.69 vs 0.58, difference = 0.12; 95% CI, 0.04-0.21; P = .005) and fundus autofluorescence-defined GA (Pearson r = 0.70 vs 0.56, difference = 0.13; 95% CI, 0.05-0.22; P = .002). On internal and external validation, the novel GA outcome measure predicted BCVA letter scores less than 36, 70, and 85 (20/200, 20/40, and 20/20, respectively) more accurately than GA area (each P < .001). Longitudinally, change in the novel GA outcome measure correlated more strongly with BCVA decline than change in GA area did (eg, Pearson r = 0.37 vs 0.28, difference = 0.09; 95% CI, 0.04-0.14; P < .001; internal validation).Conclusions and RelevanceIn this prognostic study, results suggest that the novel GA outcome measure aligned with BCVA, a
现有的追踪地理萎缩(GA)进展的结果测量方法有缺点。作为一种功能测量,最佳矫正视力(BCVA)与生活质量相关,并得到监管机构的认可,但它是主观的和嘈杂的(即,具有高水平的测试-重测试变异性)。作为一种结构测量,遗传面积是客观的,噪声较小(即,具有低水平的测试-重测试变异性),但假设所有黄斑位置都同样重要。目的推导并验证一种新的预后指标——地理萎缩加权视力指数(GAWAIN)。这是一种结构性措施,通过对排列在同心环空中的黄斑像素进行经验加权来与BCVA对齐。新的遗传算法结果测量的推导和验证。设计、环境和参与者本预后研究包括使用计算机分析的结果测量开发。训练/验证集的数据来自年龄相关眼病研究2 (AREDS2)研究的参与者(4313次就诊,1528只眼睛),外部验证集的数据来自GA米诺环素试验的参与者(218次就诊,35只眼睛)。研究数据分析时间为2025年4月至10月。新型GA结局指标(0-100)与BCVA(35-85字母评分)的相关性;临床BCVA阈值的受试者工作特征曲线下面积。黄斑分为60个同心环空;计算每个环的GA占用率。使用脊回归计算环的重量,以每个环的GA累及和年龄为预测因子,以BCVA缺陷(100 - BCVA)为结果。结果对1120名参与者(平均[SD]年龄77.1[7.0]岁,女性645名[57.6%])进行了筛选/验证,对35名参与者(平均[SD]年龄74.3[7.1]岁,女性21名[60.0%])进行了外部验证。随着黄斑偏心率的增加,黄斑环重呈减速下降趋势。在内部验证中,与GA面积相比,新的GA结果测量与BCVA缺陷的相关性更强(Pearson r = 0.58 vs 0.32,差异= 0.27;95% CI, 0.23-0.31; P < 0.001)。彩色眼底照片定义GA的外部验证也是如此(皮尔逊r = 0.69 vs 0.58,差异= 0.12;95% CI, 0.04-0.21; P =。005)和眼底自身荧光定义的GA (Pearson r = 0.70 vs 0.56,差异= 0.13;95% CI, 0.05-0.22; P = 0.002)。在内部和外部验证中,新的GA结果测量预测BCVA字母得分小于36、70和85(分别为20/200、20/40和20/20)比GA面积更准确(P < 0.001)。纵向上,与GA面积变化相比,新型GA结果测量值的变化与BCVA下降的相关性更强(例如,Pearson r = 0.37 vs 0.28,差异= 0.09;95% CI, 0.04-0.14; P < 0.001;内部验证)。结论和相关性在这项预后研究中,结果表明,通过同心环空的经验加权,新的GA结局指标与BCVA一致,BCVA是一个关键的功能结局指标。这为客观地跟踪预测功能下降提供了替代措施,比GA面积更有意义。
{"title":"Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure.","authors":"Jintong Hou,Leon von der Emde,Souvick Mukherjee,Emily Vance,Elvira Agrón,Amitha Domalpally,Emily Y Chew,Tiarnán D L Keenan, ","doi":"10.1001/jamaophthalmol.2025.6002","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.6002","url":null,"abstract":"ImportanceExisting outcome measures for tracking geographic atrophy (GA) progression have disadvantages. As a functional measure, best-corrected visual acuity (BCVA) is associated with quality of life and recognized by regulators but is subjective and noisy (ie, with a high level of test-retest variability). As a structural measure, GA area is objective and less noisy (ie, with a low level of test-retest variability) but assumes all macular locations are equally important.ObjectiveTo derive and validate a novel outcome measure, the Geographic Atrophy Weighted-by-Acuity Index (GAWAIN). This was designed as a structural measure to align with BCVA by empirical weighting of macular pixels arranged in concentric annuli.ExposuresDerivation and validation of novel GA outcome measure.Design, Setting, and ParticipantsThis prognostic study included outcome measure development using in silico analyses. The data for the training/validation set were taken from participants in the Age-Related Eye Disease Study 2 (AREDS2) study (4313 visits, 1528 eyes), and for the external validation set, data were taken from participants in the GA Minocycline Trial (218 visits, 35 eyes). Study data were analyzed from April to October 2025.Main Outcomes and MeasuresPearson correlation between the novel GA outcome measure (0-100) and BCVA (35-85 letter score); area under receiver operating characteristic curve for clinical BCVA thresholds. The macula was divided into 60 concentric annuli; GA occupancy of each annulus was calculated. Annulus weights were derived using ridge regression, with GA involvement of each annulus and age as predictors and BCVA deficit (100 - BCVA) as outcome.ResultsTraining/validation was performed on 1120 participants (mean [SD] age, 77.1 [7.0] years; 645 female [57.6%]), and external validation was performed on 35 participants (mean [SD] age, 74.3 [7.1] years; 21 female [60.0%]). The annulus weights exhibited a decelerating decline with macular eccentricity. On internal validation, the novel GA outcome measure was correlated more strongly with BCVA deficit than GA area (Pearson r = 0.58 vs 0.32, difference = 0.27; 95% CI, 0.23-0.31; P &lt; .001). This was also true on external validation for color fundus photograph-defined GA (Pearson r = 0.69 vs 0.58, difference = 0.12; 95% CI, 0.04-0.21; P = .005) and fundus autofluorescence-defined GA (Pearson r = 0.70 vs 0.56, difference = 0.13; 95% CI, 0.05-0.22; P = .002). On internal and external validation, the novel GA outcome measure predicted BCVA letter scores less than 36, 70, and 85 (20/200, 20/40, and 20/20, respectively) more accurately than GA area (each P &lt; .001). Longitudinally, change in the novel GA outcome measure correlated more strongly with BCVA decline than change in GA area did (eg, Pearson r = 0.37 vs 0.28, difference = 0.09; 95% CI, 0.04-0.14; P &lt; .001; internal validation).Conclusions and RelevanceIn this prognostic study, results suggest that the novel GA outcome measure aligned with BCVA, a","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"93 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Language Concordance in Ophthalmic Care-Equity Implications. 评估眼科护理的语言一致性-公平意义。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-29 DOI: 10.1001/jamaophthalmol.2025.5982
Sajad Besharati,Vahid Mohammadzadeh,Kouros Nouri-Mahdavi
{"title":"Evaluating Language Concordance in Ophthalmic Care-Equity Implications.","authors":"Sajad Besharati,Vahid Mohammadzadeh,Kouros Nouri-Mahdavi","doi":"10.1001/jamaophthalmol.2025.5982","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5982","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"19 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Context for Large Language Model Evaluation in Ophthalmology. 眼科学中大语言模型评估的背景。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-22 DOI: 10.1001/jamaophthalmol.2025.5841
Yusuke Kameda,Yutaka Kaneko
{"title":"Context for Large Language Model Evaluation in Ophthalmology.","authors":"Yusuke Kameda,Yutaka Kaneko","doi":"10.1001/jamaophthalmol.2025.5841","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5841","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"4 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Context for Large Language Model Evaluation in Ophthalmology. 眼科学中大语言模型评估的背景。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-22 DOI: 10.1001/jamaophthalmol.2025.5844
James Doherty,Sara Lovasz
{"title":"Context for Large Language Model Evaluation in Ophthalmology.","authors":"James Doherty,Sara Lovasz","doi":"10.1001/jamaophthalmol.2025.5844","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5844","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"92 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Context for Large Language Model Evaluation in Ophthalmology-Reply. 眼科学中大语言模型评价的背景——回复。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-22 DOI: 10.1001/jamaophthalmol.2025.5847
Sahana Srinivasan,Qingyu Chen,Yih Chung Tham
{"title":"Context for Large Language Model Evaluation in Ophthalmology-Reply.","authors":"Sahana Srinivasan,Qingyu Chen,Yih Chung Tham","doi":"10.1001/jamaophthalmol.2025.5847","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5847","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"7 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome Metrics in Myopia Control Trials. 近视对照试验的结果指标。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5768
Benjamin G Jastrzembski,John Robert Mark,Nandini Gandhi
{"title":"Outcome Metrics in Myopia Control Trials.","authors":"Benjamin G Jastrzembski,John Robert Mark,Nandini Gandhi","doi":"10.1001/jamaophthalmol.2025.5768","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5768","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"5 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pedunculated Palpebral Conjunctival Papilloma 带蒂眼睑结膜乳头状瘤
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5767
Wisam O. Najdawi, Justin Chen, Carol L. Karp
This case report describes the diagnosis and treatment of conjunctival papilloma in a patient aged 54 years who presented with a 3-month history of a painless lower left eyelid lesion.
本病例报告描述了结膜乳头状瘤的诊断和治疗,患者年龄54岁,表现为3个月的无痛左下眼睑病变史。
{"title":"Pedunculated Palpebral Conjunctival Papilloma","authors":"Wisam O. Najdawi, Justin Chen, Carol L. Karp","doi":"10.1001/jamaophthalmol.2025.5767","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5767","url":null,"abstract":"This case report describes the diagnosis and treatment of conjunctival papilloma in a patient aged 54 years who presented with a 3-month history of a painless lower left eyelid lesion.","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"8 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Language Accessibility at Select Academic Ophthalmology Centers Across US Metropolitan Areas 在美国大都市地区选择学术眼科中心的语言可访问性
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5751
Sebastian Borges, Nicholas J. DeLuca, Victoria A. Pereira, Vitalia Borges, Kara M. Cavuoto
Importance Language concordance between patients and physicians may improve health outcomes; the extent to which academic ophthalmology centers meet the needs of limited English proficiency populations remains unclear. Objective To evaluate alignment between ophthalmologists language skills at US academic ophthalmology centers and linguistic needs of surrounding limited English proficiency populations. Design, Setting, and Participants This cross-sectional study included ophthalmologists affiliated with 32 ophthalmology programs across 28 metropolitan areas, identified from overlap of 2024-2025 <jats:italic toggle="yes">US News &amp;amp; World Report</jats:italic> “Best Hospitals for Ophthalmology” rankings and 2024 Blue Ridge Institute for Medical Research data on National Institutes of Health funding. Language and training data were collected from institutional websites and public sources. Exposures Ophthalmologist language offerings and local limited English proficiency (LEP) language composition derived from institutional websites and US Census Bureau American Community Survey data. Main Outcomes and Measures Language coverage (proportion of limited English proficiency languages represented by ophthalmologists), adjusted ratios (proportion of ophthalmologists speaking a language relative to the limited English proficiency population speaking it), and ophthalmologist availability (number of ophthalmologists per 10 000 limited English proficiency patients). Regional differences were tested using χ <jats:sup>2</jats:sup> and ANOVA tests. Results A mean of 330 (range, 314-367) ophthalmologists were evaluated per region. Across regions, total coverage was 45 of 82 ophthalmologists (54.9%) in the Northeast, 31 of 59 (52.5%) in the South, 29 of 72 (40.3%) in the West, and 24 of 74 (32.4%) in the Midwest. Coverage in the Midwest was lower than in the Northeast (difference, −0.22; 95% CI, −0.42 to −0.02; <jats:italic toggle="yes">P</jats:italic> = .03). Across 49 identified languages, only Spanish (mean adjusted ratio, 0.64 [95% CI, 0.28-1.00]) and Vietnamese (mean adjusted ratio, 0.86 [95% CI, 0.05-1.67]) were present in every region with consistent underrepresentation. Ophthalmologist availability was lowest for Spanish (mean adjusted ratio, 4.97 [95% CI, −4.49 to 14.43] per 10 000 limited English proficiency patients overall; &amp;lt;3.0 in 3 regions) and Chinese (mean adjusted ratio, 33.25 [95% CI, −33.26 to 99.76] per 10 000). Conclusions and Relevance In this cross-sectional study, academic ophthalmology centers demonstrated substantial gaps in language concordance, with Spanish-speaking patients disproportionately affected despite representing the largest limited English proficiency population nationally. These findings extend prior evidence of patient-level disparities by identifying potential workforce-level contributors to inequities in ophthalmic care and support targeted recruitment, training, and reporting strategies to expand Spa
患者和医生之间的语言一致性可以改善健康结果;学术眼科中心在多大程度上满足英语水平有限的人群的需求仍不清楚。目的评估美国眼科学术中心眼科医生的语言技能与周边有限英语熟练人群的语言需求之间的一致性。设计、环境和参与者本横断面研究包括28个大都市地区32个眼科项目的眼科医生,从2024-2025年US News的重叠部分确定。世界报告“最佳眼科医院”排名和2024年蓝岭医学研究所的数据由美国国立卫生研究院资助。语言和培训数据收集自机构网站和公共资源。来自机构网站和美国人口普查局美国社区调查数据的眼科医生语言产品和当地有限英语水平(LEP)语言组成。语言覆盖率(眼科医生所代表的有限英语熟练语言的比例)、调整比率(说一种语言的眼科医生相对于说这种语言的有限英语熟练人群的比例)和眼科医生可获得性(每1万名有限英语熟练患者的眼科医生人数)。采用χ 2和方差分析检验区域差异。结果每个地区平均有330名眼科医生(范围314-367)接受评估。从地区来看,东北地区82名眼科医生中有45名(54.9%),南部地区59名眼科医生中有31名(52.5%),西部地区72名眼科医生中有29名(40.3%),中西部地区74名眼科医生中有24名(32.4%)。中西部地区的覆盖率低于东北部(差异为- 0.22;95% CI, - 0.42至- 0.02;P = .03)。在49种确定的语言中,只有西班牙语(平均校正比,0.64 [95% CI, 0.28-1.00])和越南语(平均校正比,0.86 [95% CI, 0.05-1.67])在每个地区都存在一致的代表性不足。西班牙语(平均校正比为4.97 [95% CI, - 4.49至14.43]/ 1万名有限英语水平患者;3个地区为3.0)和汉语(平均校正比为33.25 [95% CI, - 33.26至99.76]/ 1万名)眼科医生的可用性最低。在这项横断面研究中,学术眼科中心显示了语言一致性的巨大差距,西班牙语患者受到的影响不成比例,尽管他们代表了全国最大的有限英语熟练人群。这些发现通过确定眼科护理不平等的潜在劳动力水平因素,扩展了先前患者水平差异的证据,并支持有针对性的招聘、培训和报告策略,以扩大西班牙语能力并解决特定地区的短缺问题。
{"title":"Language Accessibility at Select Academic Ophthalmology Centers Across US Metropolitan Areas","authors":"Sebastian Borges, Nicholas J. DeLuca, Victoria A. Pereira, Vitalia Borges, Kara M. Cavuoto","doi":"10.1001/jamaophthalmol.2025.5751","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5751","url":null,"abstract":"Importance Language concordance between patients and physicians may improve health outcomes; the extent to which academic ophthalmology centers meet the needs of limited English proficiency populations remains unclear. Objective To evaluate alignment between ophthalmologists language skills at US academic ophthalmology centers and linguistic needs of surrounding limited English proficiency populations. Design, Setting, and Participants This cross-sectional study included ophthalmologists affiliated with 32 ophthalmology programs across 28 metropolitan areas, identified from overlap of 2024-2025 &lt;jats:italic toggle=\"yes\"&gt;US News &amp;amp;amp; World Report&lt;/jats:italic&gt; “Best Hospitals for Ophthalmology” rankings and 2024 Blue Ridge Institute for Medical Research data on National Institutes of Health funding. Language and training data were collected from institutional websites and public sources. Exposures Ophthalmologist language offerings and local limited English proficiency (LEP) language composition derived from institutional websites and US Census Bureau American Community Survey data. Main Outcomes and Measures Language coverage (proportion of limited English proficiency languages represented by ophthalmologists), adjusted ratios (proportion of ophthalmologists speaking a language relative to the limited English proficiency population speaking it), and ophthalmologist availability (number of ophthalmologists per 10 000 limited English proficiency patients). Regional differences were tested using χ &lt;jats:sup&gt;2&lt;/jats:sup&gt; and ANOVA tests. Results A mean of 330 (range, 314-367) ophthalmologists were evaluated per region. Across regions, total coverage was 45 of 82 ophthalmologists (54.9%) in the Northeast, 31 of 59 (52.5%) in the South, 29 of 72 (40.3%) in the West, and 24 of 74 (32.4%) in the Midwest. Coverage in the Midwest was lower than in the Northeast (difference, −0.22; 95% CI, −0.42 to −0.02; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .03). Across 49 identified languages, only Spanish (mean adjusted ratio, 0.64 [95% CI, 0.28-1.00]) and Vietnamese (mean adjusted ratio, 0.86 [95% CI, 0.05-1.67]) were present in every region with consistent underrepresentation. Ophthalmologist availability was lowest for Spanish (mean adjusted ratio, 4.97 [95% CI, −4.49 to 14.43] per 10 000 limited English proficiency patients overall; &amp;amp;lt;3.0 in 3 regions) and Chinese (mean adjusted ratio, 33.25 [95% CI, −33.26 to 99.76] per 10 000). Conclusions and Relevance In this cross-sectional study, academic ophthalmology centers demonstrated substantial gaps in language concordance, with Spanish-speaking patients disproportionately affected despite representing the largest limited English proficiency population nationally. These findings extend prior evidence of patient-level disparities by identifying potential workforce-level contributors to inequities in ophthalmic care and support targeted recruitment, training, and reporting strategies to expand Spa","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"18 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome Metrics in Myopia Control Trials-Reply. 近视控制试验的结果指标-回复。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5771
Jianfeng Zhu,Hannan Xu,Xun Xu
{"title":"Outcome Metrics in Myopia Control Trials-Reply.","authors":"Jianfeng Zhu,Hannan Xu,Xun Xu","doi":"10.1001/jamaophthalmol.2025.5771","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5771","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"20 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1